No Data
No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Cantor Fitzgerald Maintains Organogenesis(ORGO.US) With Buy Rating, Maintains Target Price $6
Organogenesis Shares Are Trading Higher After Morgan Stanley Raised Its Price on the Stock From $4 to $6.
Organogenesis Holdings Is Maintained at Equal-Weight by Morgan Stanley
Organogenesis Holdings Analyst Ratings